Press

PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer

Oct 20 • 2 min read

PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), announced today that it will be proceeding with the consolidation of its common shares (the “Common Shares“) on the basis of seven (7) pre consolidated Common Shares into one (1) post consolidated Common Share (the “Share Consolidation“). The effective date for the Share Consolidation will…

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

Oct 20 • 7 min read

Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international clinical-stage leader in psychedelic-based therapeutics Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions today published its financial results for…

Brain & Behavior Research Foundation Awards $10.2 Million in Young Investigator Grants to 150 Mental Health Scientists

Oct 20 • 4 min read

The Brain & Behavior Research Foundation today announced it is awarding $10.2 million in Young Investigator Grants to 150 promising early career scientists who are working to identify causes, improve treatments, and develop methods of prevention for psychiatric illnesses that impact millions of people in the United States and around the world. The 2023 Young Investigators are…

Red Light Holland’s Fully Owned Subsidiary, Radix Motion, Granted Patent for 3D Movement Data and AI Innovations

Oct 19 • 4 min read

-Radix Motion granted U.S. Patent No. 11,806,162 for its movement data and AI technology -Issuing date for patent is set for November 7th, 2023 “It’s amazing to realize how far we have gone in such a short time. I’m proud that our embodied technology can help establish responsible best practices around psychedelics and contribute to…

Pioneers and Innovators in Psilocybin Treatments and How Big Pharma wants in on the Psychedelic Sector

Oct 19 • 9 min read

Investorideas.com (https://www.investorideas.com) a global investor news source covering psilocybin and psychedelic health and wellness stocks releases a special news report featuring Kaya Holdings, Inc. (OTCQB:KAYS). As psilocybin and other alternative health innovators try to shape the future of mental health, Pharma and traditional healthcare investors are watching and waiting to get their share. According to…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438